Draft Genome Sequence of a Multidrug-Resistant Sequence Type 231 Outbreak-Associated Clone of Klebsiella pneumoniae, KP41-2015, Producing OXA-232 Carbapenemase

M H F Abdul Momin; A Liakopoulos; D W Wareham

doi:10.1128/genomeA.00604-17

Draft Genome Sequence of a Multidrug-Resistant Sequence Type 231 Outbreak-Associated Clone of Klebsiella pneumoniae, KP41-2015, Producing OXA-232 Carbapenemase

Genome Announc. 2017 Jul 6;5(27):e00604-17. doi: 10.1128/genomeA.00604-17.

Authors

M H F Abdul Momin^{1

2}, A Liakopoulos³, D W Wareham^{4

5}

Affiliations

¹ Antimicrobial Research Group, Blizard Institute, Barts & the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
² Microbiology Laboratory Services, RIPAS Hospital, Bandar Seri Begawan, Brunei.
³ Department of Bacteriology and Epidemiology, CVI of Wageningen University, Lelystad, The Netherlands.
⁴ Antimicrobial Research Group, Blizard Institute, Barts & the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom d.w.wareham@qmul.ac.uk.
⁵ Division of Infection, Barts Healthcare NHS Trust, London, United Kingdom.

Abstract

Carbapenem-resistant Klebsiella pneumoniae infection is a rising public health threat due to limited therapeutic options. Here, we report the genome sequence of a multidrug-resistant K. pneumoniae sequence type 231 (ST231) strain associated with an outbreak of infections in an intensive care unit that carries a unique complement of resistance determinants.